QT
BBNX

Quantbot Technologies’s Beta Bionics BBNX Stock Holding History

Quantbot Technologies’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$414K Sell
41,295
-48,110
-54% -$712K 0.02% 925
2025
Q4 		$2.72M Buy
89,405
+75,011
+521% +$2M 0.09% 351
2025
Q3 		$286K Buy
+14,394
New +$253K 0.01% 1190

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Quantbot Technologies's BBNX Position: Q1 2026 in Review

Quantbot Technologies reduced its Beta Bionics (BBNX) stake by 54% in Q1 2026, selling an estimated $712K and leaving 41,295 shares worth $414K. The position accounts for 0.02% of the portfolio, ranked #925.

Quantbot Technologies first reported a position in BBNX in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.72M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Quantbot Technologies held 41,295 shares of Beta Bionics worth $414K as of Q1 2026.
  • Quantbot Technologies sold 48,110 Beta Bionics shares in Q1 2026, an estimated $712K.
  • Beta Bionics made up 0.02% of Quantbot Technologies's portfolio in Q1 2026, its #925 holding.
  • Quantbot Technologies first reported a position in Beta Bionics in Q3 2025 and has held it in 3 quarters since.
  • Quantbot Technologies's Beta Bionics position peaked at $2.72M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.